Symbicort brought in worldwide sales of $2.7 billion last year, with $1.1 billion of that coming from the US market, where an authorised generic sold under license from AZ has been available since ...

A US court has upheld AstraZeneca’s patents on its respiratory drug Symbicort, blocking cheaper ... with a fast action, in a single inhaler. A Viatris spokesperson said: "Viatris obviously ...

Massachusetts families are still struggling to find alternatives almost a year after GlaxoSmithKline canceled a widely ...

Dublin, Dec. 05, 2024 (GLOBE NEWSWIRE) -- The "Digital Dose Inhaler Market by Type of Inhaler, Application, End-user, Component, Delivery Route, Prescription Type, Patient Age Group, Product ...

Efforts to supplant pressurised metered-dose inhalers (pMDIs ... inhalers can be a route towards these goals. AstraZeneca’s Symbicort inhaler accounts for most of its inhalation portfolio ...

According to Coherent Market Insights, the global digital dose inhaler market size is estimated to be valued at USD 18.33 billion in 2024 and is expected to surpass USD 64.33 billion by 2031, growing ...

Xanax (alprazolam) is a prescription drug that’s used to treat anxiety and panic attacks. The drug comes as a tablet that you swallow. It’s usually taken three times daily. Xanax is used to ...

Restasis (cyclosporine) is a brand-name drug that’s prescribed for chronic dry eye in adults and certain children. Restasis comes as an eye drop solution. The typical dosage is one drop per ...

Vitamin D dosage recommendations can vary depending on several factors, including your age, skin color, medical history, and where you live. Vitamin D is commonly known as the “sunshine vitamin.” ...

Dexamethasone oral tablet is a generic drug that’s prescribed for many conditions, including allergic reactions and inflammation. Dexamethasone belongs to a class of drugs called corticosteroids ...